OMECARDIO trial: a randomized, double-blind, placebo-controlled study on the impact of omega-3 on inflammageing biomarkers and vascular stiffness in hypertensive and dyslipidemic patients
1 September 2025 (11:15 - 12:00)
Organised by: 
About the speaker
Austral University Hospital, Pilar (Argentina)
5 More presentations in this session
Doctor E. Kringeland (Bergen, NO)
Miss N. Xiong (Nanjing, CN)
Doctor M. Wang (Shanghai, CN)
Access the full session
The Event
ESC Congress 2025
1 September 2025
11:15 CET
You may be interested in
Congress Presentation
Congress Session
